Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lupin receives FDA approval for generic Triamcinolone Acetonide Ointment

      Lupin receives FDA approval for generic Triamcinolone Acetonide Ointment

      Medical Dialogues Bureau23 Oct 2018 12:42 PM IST
      New Delhi: Pharma major Lupin announced that it has received approval for its Triamcinolone Acetonide Ointment USP, 0.1% from the United States Food...
      GSK Pharma Q2 profit down 23 Percent to Rs 101 crore

      GSK Pharma Q2 profit down 23 Percent to Rs 101 crore

      Medical Dialogues Bureau23 Oct 2018 10:03 AM IST
      New Delhi: GlaxoSmithKline(GSK)Pharmaceuticals has reported 22.67 per cent fall in standalone net profit to Rs 100.77 crore for the quarter ended...
      IAVI Serum Institute to Develop Affordable Antibody Products for HIV

      IAVI Serum Institute to Develop Affordable Antibody Products for HIV

      Medical Dialogues Bureau23 Oct 2018 10:00 AM IST
      New Delhi: The International AIDS Vaccine Initiative (IAVI) and Serum Institute of India, the world's largest vaccine manufacturer, today announced a...
      Strides Pharma gets USFDA approval for Gabapentin capsules

      Strides Pharma gets USFDA approval for Gabapentin capsules

      Medical Dialogues Bureau23 Oct 2018 9:10 AM IST
      Banglore: Strides Pharmaceutical Science’s step-down wholly-own subsidiary, Strides Pharma Global, Singapore, has received approval for Gabapentin...
      Unichem gets EIR from USFDA for Pithampur, Roha facilities

      Unichem gets EIR from USFDA for Pithampur, Roha facilities

      Medical Dialogues Bureau23 Oct 2018 9:00 AM IST
      New Delhi: Drug firm Unichem Laboratories has recently announced its active pharmaceutical ingredient (API) manufacturing units at Pithampur and Roha...
      Tata Iodised Salt urges the nation to pay attention to the missing “I”

      Tata Iodised Salt urges the nation to pay attention to the missing “I”

      Medical Dialogues Bureau22 Oct 2018 3:24 PM IST
      “I” is the symbol for the element Iodine. According to WHO, iodine deficiency in foetal life and early childhood remains the single most important and...
      USFDA not mandatory for Medical Devices: DOP releases Guideline for public procurement

      USFDA not mandatory for Medical Devices: DOP releases Guideline for public procurement

      Medical Dialogues Bureau22 Oct 2018 2:05 PM IST
      New Delhi: Giving relief to domestic medical device makers, the government has asked the procurement agencies to follow the Bureau of Indian Standards...
      Lupin antimyotonic agent receives positive opinion from EMA

      Lupin antimyotonic agent receives positive opinion from EMA

      Medical Dialogues Bureau22 Oct 2018 1:48 PM IST
      NaMuscla is an antimyotonic agent which is under review by the European Medicines Agency to treat symptomatic myotonia in adults with non-dystrophic...
      J&J hip implants: Affected patients seek clarity on report on compensation amount

      J&J hip implants: Affected patients seek clarity on report on compensation amount

      Medical Dialogues Bureau22 Oct 2018 9:40 AM IST
      New Delhi: Amid reports that the victims of Johnson & Johnson's faulty hip implants are likely to get as much as Rs 1.2 crore each in...
      AstraZeneca Lynparza shown to put brakes on ovarian cancer

      AstraZeneca Lynparza shown to put brakes on ovarian cancer

      Medical Dialogues Bureau22 Oct 2018 9:20 AM IST
      MUNICH - An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a...
      Lupin gets USFDA nod for psoriasis treatment spray

      Lupin gets USFDA nod for psoriasis treatment spray

      Medical Dialogues Bureau22 Oct 2018 9:03 AM IST
      New Delhi: Drug major Lupin today said it has received approval from the US health regulator to market Desoximetasone Topical spray, used for...
      Merck KGaA says might strike partnership deal this year

      Merck KGaA says might strike partnership deal this year

      Medical Dialogues Bureau22 Oct 2018 9:00 AM IST
      MUNICH: German drugmaker Merck KGaA might agree on partnership deals to jointly develop two of its most promising experimental medicines with a rival...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok